View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
March 8, 2019

Medical devices industry M&As in Q4 2018 total $9.21bn globally

Total medical devices M&A deals in Q4 2018 worth $9.21bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 8.9% over the previous quarter and a rise of 40.1% when compared with the last four-quarter average, which stood at $6.68bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $4.65bn. At the country level, the United States topped the list in terms of deal value at $4.65bn.

In terms of volumes, North America emerged as the top region for medical devices M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in Q4 2018 was the United States with 42 deals, followed by the United Kingdom with four and Israel with three.

In 2018, as of the end of Q4, medical devices M&As worth $31.74bn were announced globally, marking a decrease of 75% year on year.

Medical devices M&A deals in Q4 2018: Top deals

The top five medical devices M&A deals accounted for 89.9% of the overall value during Q4 2018.

The combined value of the top five medical devices M&A deals stood at $8.27bn, against the overall value of $9.21bn recorded for the quarter.

The top announced medical devices M&A deal tracked by GlobalData in Q4 2018 was Bravo Bidco’s $4.24bn acquisition of BTG.

In second place was Colfax’s acquisition of DJO Global for $3.15bn and in third place was ConMed’s $365m acquisition of Buffalo Filter.

RTI Surgical’s $300m acquisition of Paradigm Spine and Stryker’s acquisition of HyperBranch Medical Technology for $220m held fourth and fifth positions, respectively.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

 

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU